{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:35:15Z","timestamp":1782603315641,"version":"3.54.5"},"reference-count":35,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/or.2015.4527","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T13:30:04Z","timestamp":1451309404000},"page":"1841-1850","source":"Crossref","is-referenced-by-count":20,"title":["Sosiho-tang ameliorates cachexia-related symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss"],"prefix":"10.3892","volume":"35","author":[{"given":"AEYUNG","family":"KIM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINJU","family":"IM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIN YEUL","family":"MA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"key20180107210742_b1-or-35-03-1841","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"key20180107210742_b2-or-35-03-1841","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0973-1075.73644","article-title":"Treatment of cachexia in oncology","volume":"16","author":"Tazi","year":"2010","journal-title":"Indian J Palliat Care"},{"key":"key20180107210742_b3-or-35-03-1841","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J Gastrointest Oncol"},{"key":"key20180107210742_b4-or-35-03-1841","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pan.2014.11.006","article-title":"Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review","volume":"15","author":"Ozola Zalite","year":"2015","journal-title":"Pancreatology"},{"key":"key20180107210742_b5-or-35-03-1841","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.5604\/17322693.1085135","article-title":"Systemic and local mechanisms leading to cachexia in cancer","volume":"67","author":"Grabiec","year":"2013","journal-title":"Postepy hig Med Dosw (Online)"},{"key":"key20180107210742_b6-or-35-03-1841","doi-asserted-by":"crossref","first-page":"168407","DOI":"10.1155\/2014\/168407","article-title":"Inflammation based regulation of cancer cachexia","volume":"2014","author":"Onesti","year":"2014","journal-title":"BioMed Res Int"},{"key":"key20180107210742_b7-or-35-03-1841","first-page":"1353","article-title":"Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft","volume":"1","author":"Tamura","year":"1995","journal-title":"Clin Cancer Res"},{"key":"key20180107210742_b8-or-35-03-1841","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbrc.2004.08.196","article-title":"Suppression of cancer cachexia by 20S,21-epoxy-resi bufogenin-3-acetate-a novel nonpeptide IL-6 receptor antagonist","volume":"323","author":"Enomoto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107210742_b9-or-35-03-1841","doi-asserted-by":"crossref","first-page":"e102436","DOI":"10.1371\/journal.pone.0102436","article-title":"Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer","volume":"9","author":"Ando","year":"2014","journal-title":"PLoS One"},{"key":"key20180107210742_b10-or-35-03-1841","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1517\/14656560902960162","article-title":"Medroxyprogesterone acetate in the management of cancer cachexia","volume":"10","author":"Madeddu","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"key20180107210742_b11-or-35-03-1841","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1615\/CritRevOncog.v9.i2.10","article-title":"Cytokine involvement in cancer anorexia\/cachexia: Role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms","volume":"9","author":"Mantovani","year":"1998","journal-title":"Crit Rev Oncog"},{"key":"key20180107210742_b12-or-35-03-1841","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3322\/canjclin.52.2.72","article-title":"Cancer anorexia-cachexia syndrome: Current issues in research and management","volume":"52","author":"Inui","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"key20180107210742_b13-or-35-03-1841","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1872-034X.2011.00829.x","article-title":"Therapeutic effects of the oriental herbal medicine Sho-saiko-to on liver cirrhosis and carcinoma","volume":"41","author":"Lee","year":"2011","journal-title":"Hepatol Res"},{"key":"key20180107210742_b14-or-35-03-1841","doi-asserted-by":"crossref","first-page":"D84","DOI":"10.1046\/j.1440-1746.2000.02138.x","article-title":"Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma","volume":"15","author":"Shimizu","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180107210742_b15-or-35-03-1841","first-page":"91","article-title":"Cytotoxic effect of herbal medicine Sho-saiko-to on human lung-cancer cell-lines in vitro","volume":"2","author":"Mizushima","year":"1995","journal-title":"Oncol Rep"},{"key":"key20180107210742_b16-or-35-03-1841","first-page":"448","article-title":"The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0\/G1 phase","volume":"54","author":"Yano","year":"1994","journal-title":"Cancer Res"},{"key":"key20180107210742_b17-or-35-03-1841","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.fct.2012.12.006","article-title":"Anti-inflammatory effect of Sosihotang via inhibition of nuclear factor-\u03baB and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated RAW 264.7 macrophage cells","volume":"53","author":"Oh","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"key20180107210742_b18-or-35-03-1841","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/IR:23:1:41","article-title":"IL-6-like cytokines and cancer cachexia: Consequences of chronic inflammation","volume":"23","author":"Barton","year":"2001","journal-title":"Immunol Res"},{"key":"key20180107210742_b19-or-35-03-1841","first-page":"157","article-title":"Cancer cachexia and targeting chronic inflammation: A unified approach to cancer treatment and palliative\/supportive care","volume":"5","author":"MacDonald","year":"2007","journal-title":"J Support Oncol"},{"key":"key20180107210742_b20-or-35-03-1841","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer","volume":"8","author":"Deans","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"key20180107210742_b21-or-35-03-1841","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"key20180107210742_b22-or-35-03-1841","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BJ20112024","article-title":"Myostatin is a novel tumoral factor that induces cancer cachexia","volume":"446","author":"Lokireddy","year":"2012","journal-title":"Biochem J"},{"key":"key20180107210742_b23-or-35-03-1841","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Costelli","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"key20180107210742_b24-or-35-03-1841","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0838.2005.00498.x","article-title":"The possible role of myostatin in skeletal muscle atrophy and cachexia","volume":"16","author":"Jespersen","year":"2006","journal-title":"Scand J Med Sci Sports"},{"key":"key20180107210742_b25-or-35-03-1841","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1096\/fj.00-0463","article-title":"Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB","volume":"15","author":"Langen","year":"2001","journal-title":"FASEB J"},{"key":"key20180107210742_b26-or-35-03-1841","doi-asserted-by":"crossref","first-page":"601434","DOI":"10.1155\/2011\/601434","article-title":"Cancer cachexia: Mechanisms and clinical implications","volume":"2011","author":"Donohoe","year":"2011","journal-title":"Gastroenterol Res Pract"},{"key":"key20180107210742_b27-or-35-03-1841","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1615\/CritRevOncog.v17.i3.50","article-title":"Efficacy of ghrelin in cancer cachexia: Clinical trials and a novel treatment by Rikkunshito","volume":"17","author":"Fujitsuka","year":"2012","journal-title":"Crit Rev Oncog"},{"key":"key20180107210742_b28-or-35-03-1841","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphar.2014.00271","article-title":"Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome","volume":"5","author":"Fujitsuka","year":"2014","journal-title":"Front Pharmacol"},{"key":"key20180107210742_b29-or-35-03-1841","doi-asserted-by":"crossref","first-page":"976926","DOI":"10.1155\/2012\/976926","article-title":"Hochuekkito (TJ-41), a kampo formula, ameliorates cachexia induced by colon 26 adenocarcinoma in mice","volume":"2012","author":"Yae","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"key20180107210742_b30-or-35-03-1841","doi-asserted-by":"crossref","first-page":"736563","DOI":"10.1155\/2014\/736563","article-title":"Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice","volume":"2014","author":"Choi","year":"2014","journal-title":"Mediators Inflamm"},{"key":"key20180107210742_b31-or-35-03-1841","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0304-3835(00)00496-1","article-title":"Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6","volume":"158","author":"Iizuka","year":"2000","journal-title":"Cancer Lett"},{"key":"key20180107210742_b32-or-35-03-1841","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bbrc.2011.02.111","article-title":"Inhibition of tumor growth by quercetin with increase of survival and prevention of cachexia in Walker 256 tumor-bearing rats","volume":"406","author":"Camargo","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107210742_b33-or-35-03-1841","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/08923979809031517","article-title":"Inhibitory effect of anaphylactic reaction of Sosiho-Tang","volume":"20","author":"Kim","year":"1998","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"key20180107210742_b34-or-35-03-1841","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1472-6882-13-137","article-title":"Antithrombotic and anti-platelet activities of Soshiho-tang extract","volume":"13","author":"Lee","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"key20180107210742_b35-or-35-03-1841","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/jphp.12201","article-title":"Xiaochaihutang prevents depressive-like behaviour in rodents by enhancing the serotonergic system","volume":"66","author":"Su","year":"2014","journal-title":"J Pharm Pharmacol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4527\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T21:18:42Z","timestamp":1653945522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,12,28]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/or.2015.4527"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4527","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}